STOCK TITAN

MacroGenics (MGNX) director awarded options, RSUs and exercises prior grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MACROGENICS INC director Margaret Liu reported routine equity compensation activity. She received a stock option grant for 22,000 shares of common stock at an exercise price of $4.52 per share, expiring on May 19, 2036. She was also granted 3,750 restricted stock units, each representing one share of common stock, which will vest one year after the grant date or the day before the next annual meeting, if earlier. Separately, 3,750 previously granted RSUs vested on May 18, 2026 and were exercised into 3,750 shares of common stock, bringing her direct common stock holdings to 14,750 shares.

Positive

  • None.

Negative

  • None.
Insider Liu Margaret
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 3,750 $0.00 --
Grant/Award Stock Option (right to buy) 22,000 $0.00 --
Exercise Restricted Stock Unit 3,750 $0.00 --
Exercise Common Stock 3,750 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 3,750 shares (Direct, null); Stock Option (right to buy) — 22,000 shares (Direct, null); Common Stock — 14,750 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
Option grant size 22,000 shares Stock option (right to buy) granted on May 19, 2026
Option exercise price $4.52 per share Exercise price of stock option expiring May 19, 2036
New RSU grant 3,750 units Restricted Stock Unit award on May 19, 2026
RSUs exercised 3,750 units Previously granted RSUs exercised into common stock on May 18, 2026
Common shares held after 14,750 shares Direct MACROGENICS INC common stock holdings after RSU exercise
Option expiration May 19, 2036 Expiration date of 22,000-share stock option grant
Restricted Stock Unit financial
"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (right to buy financial
"security_title: "Stock Option (right to buy)" with 22,000.0000 shares granted."
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for RSUs converted into common stock."
vest financial
"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
cumulative 1/12th increments financial
"The option will vest and become exercisable in monthly, cumulative 1/12th increments beginning one month from the date of grant."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Liu Margaret

(Last)(First)(Middle)
9704 MEDICAL CENTER DRIVE

(Street)
ROCKVILLE MARYLAND 20850

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MACROGENICS INC [ MGNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/18/2026M3,750A(1)14,750D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit$0(1)05/18/2026M3,750 (2) (2)Common Stock3,750$00D
Restricted Stock Unit$0(1)05/19/2026A3,750 (3) (3)Common Stock3,750$03,750D
Stock Option (right to buy)$4.5205/19/2026A22,000 (4)05/19/2036Common Stock22,000$022,000D
Explanation of Responses:
1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
2. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026.
3. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
4. The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
Remarks:
Beth A. Smith, Attorney-in-fact05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Margaret Liu report at MACROGENICS INC (MGNX)?

Margaret Liu reported equity awards and an RSU vesting at MACROGENICS INC. She received new stock options and restricted stock units and converted previously granted RSUs into common shares, increasing her direct stock holdings through routine compensation-related transactions.

How many stock options did Margaret Liu receive from MACROGENICS INC (MGNX)?

She received a stock option grant covering 22,000 shares of MACROGENICS INC common stock. These options carry an exercise price of $4.52 per share and will expire on May 19, 2036, vesting in monthly 1/12th increments beginning one month after the grant date.

What restricted stock unit (RSU) awards did Margaret Liu receive from MGNX?

She was granted 3,750 restricted stock units, each representing one share of MACROGENICS INC common stock. According to the terms, the RSUs will vest one year after the grant date or on the day prior to the next annual meeting of stockholders, whichever occurs first.

What RSU vesting and share acquisition did Margaret Liu report for MGNX?

On May 18, 2026, 3,750 previously granted RSUs vested and were exercised into 3,750 shares of MACROGENICS INC common stock. This derivative exercise increased her direct ownership, bringing her reported common stock holdings to 14,750 shares following the transaction.

How many MACROGENICS INC shares does Margaret Liu hold after these transactions?

Following the reported RSU exercise, Margaret Liu directly holds 14,750 shares of MACROGENICS INC common stock. This figure reflects shares acquired upon vesting of 3,750 restricted stock units on May 18, 2026, as shown in her Form 4 filing.

How do Margaret Liu’s option grants at MGNX vest over time?

Her 22,000-share stock option grant vests in monthly, cumulative 1/12th increments starting one month from the grant date. Each month, an additional portion becomes exercisable, with rounding upward to whole shares, until the option fully vests before its May 19, 2036 expiration.